Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer
ConclusionSIRT1/FoxO1/SREBP-1 act as a pathway targeting PR and involve in the development of progestin resistance in Ishikawa cells.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research
More News: Cancer | Cancer & Oncology | Endometrial Cancer | Medroxyprogesterone | OBGYN | Reproduction Medicine | Study